References
- Api AM, Basketter DA, Cadby PA, Cano MF, Ellis G, Gerberick GF, Griem P, McNamee PM, Ryan CA, Safford R. 2008. Dermal sensitization quantitative risk assessment (QRA) for fragrance ingredients. Regul Toxicol Pharmacol 52:3–23.
- Babu RJ, Chatterjee A, Ahaghotu E, Singh M. 2004. Percutaneous absorption and skin irritation upon low-level prolonged dermal exposure to nonane, dodecane and tetradecane in hairless rats. Toxicol Ind Health 20:109–118.
- Basketter DA, Lea LJ, Dickens A, Briggs D, Pate I, Dearman RJ, Kimber I. 1999. A comparison of statistical approaches to the derivation of EC3 values from Local Lymph Node Assay dose responses. J Appl Toxicol 19:261–266.
- Basketter DA, Roberts DW, Cronin M, Scholes EW. 1992. The value of the Local Lymph Node Assay in quantitative structure-activity investigations. Contact Dermat 27:137–142.
- Brand RM, Charron AR, Dutton L, Gavlik TL, Mueller C, Hamel FG, Chakkalakal D, Donohue TM Jr. 2004. Effects of chronic alcohol consumption on dermal penetration of pesticides in rats. J Toxicol Environ Health 67:153–161.
- COSHH. 2009. Dermatitis and other skin disorders. Available online at: http://www.hse.gov.uk/statistics/causdis/dermatitis/index.htm (Website accessed December 31, 2009)
- ECETOC (European Centre for Ecotoxicology and Toxicology of Chemicals). 2003. Contact sensitisation: Classification according to potency, a commentary. Technical Report No. 43, Brussels, Belgium: ECETOC.
- Fedorowicz A, Singh H, Soderholm S, Demchuk E. 2005. Structure-activity models for contact sensitization. Chem Res Toxicol 18:954–969.
- Gerberick GF, Ryan CA, Dearman RJ, Kimber I. 2007. Local Lymph Node Assay (LLNA) for detection of sensitization capacity of chemicals. Methods 41:54–60.
- Hilton J, Dearman RJ, Harvey P, Evans P, Basketter DA, Kimber I. 1998. Estimation of relative skin sensitizing potency using the Local Lymph Node Assay: a comparison of formaldehyde with glutaraldehyde. Am J Contact Dermat 9:29–33.
- Jumaa M. Carlson B, Chimilio L, Silchenko S, Stella VJ. 2004. Kinetics and mechanism of degradation of epothilone-D: an experimental anticancer agent. J Pharm Sci 93:2953–2961.
- Kimber I, Basketter DA. 1997. Contact sensitization: a new approach to risk assessment. Human Ecol Risk Assess 3:385–395.
- Kimber I, Dearman RJ, Basketter DA, Ryan CA, Gerberick GF, McNamee PM, Lalko J, Api AM. 2008. Dose metrics in the acquisition of skin sensitization: thresholds and importance of dose per unit area. Regul Toxicol Pharmacol 52:39–45.
- Kobayashi K, Yoshimoto K, Hirauchi K, Uchida K. 1993. Deglycation of glycated proteins with hydrazine analogs. Life Sci 53:291–295.
- Moss GP, Dearden JC, Patel H, Cronin MT. 2002. Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption. Toxicol In Vitro 16:299–317.
- NIOSH. 2009. NIOSH.Safety and Health Topic: Skin exposures & effects. National Institute of Occupational Safety and Health. Education and Information Division. Available online at: http://www.cdc.gov/niosh.topics/skin/ (Website accessed December 31, 2009)
- OSHA. 2005. Health and Safety Page, Dermal Exposure. Available online at: http://www.osha.gov/SLTC/dermalexposure/index.html (Website accessed December 31, 2009)
- Potts RO, Guy RH. 1992. Predicting skin permeability. Pharm Res. 9:663–669.
- Ryan CA, Chaney JG, Gerberick GF, Kern PS, Dearman RJ, Kimber I, Basketter DA. 2007. Extrapolating local lymph node assay EC3 values to estimate relative sensitizing potency Cutan Ocul Toxicol 26:135–145.